Published on: 25 August 2016
Skip to main content
Published on: 25 August 2016
Published on: 5 August 2016
Published on: 20 May 2013
Published on: 4 October 2013
Published on: 25 November 2014
The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache
Stovner L.J., Al Jumah M., Birbeck G.L. et al.
Headache disorders are third cause of disability worldwide
Steiner T.J., Birbeck G.L., Jensen R.H. et al.
Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire
Steiner T. J., Gururaj G., Andree C. et al.
The impact of headache in Europe: principal results of the Eurolight project
Steiner T. J., Stovner L.J., Katsarava Z. et al.
Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
Martelletti P. Katsarava Z. Lampl C. et al.
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation
Mitsikostas D.D., Edvinsson L. Jensen R.J. et al.
Patient-conducted anodal transcranial direct current stimulation of the motor cortex alleviates pain Di Stefano G., La Cesa S., Truini A., Cruccu G. et al.in trigeminal neuralgia
Hagenacker T., Bude V., Naegel S. et al.
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK
Khalil M., Zafar H.W., Quarshie V. et al.
The evolution of headache from childhood to adulthood: a review of the literature
Antonaci F., Voiticovschi-Iosob C., Di Stefano A.L. et al.
The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study
Kim S-Y. and Park S-P.
Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
Di Stefano G., La Cesa S., Truini A. et al.
A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome
Cheng Y-C., Kuo K-H. and Lai T-H.
(Publication years 2014-2015. Data collected June 2016. Source: Web of Science)
Cost-effectiveness analysis of non-invasive vagus nerve stimulation for the treatment of chronic cluster headache
Morris J., Straube A., Diener H-C. et al.
European headache federation consensus on technical investigation for primary headache disorders
Mitsikostas D.D., Ashina M., Craven A. et al.
Electronic behavioral interventions for headache: a systematic review
Minen M.T., Torous J., Raynowska J. et al.
Altered serum levels of kynurenine metabolites in patients affected by cluster headache
Curto M., Lionetto L., Negro A. et al.
Impact of migraine on fibromyalgia symptoms
Giamberardino M.A., Affaitati G., Martelletti P. et al.
Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto M., Lionetto L., Negro A. et al.
Comorbidities of psychiatric and headache disorders in Nepal: implications from a nationwide population-based study
Risal A., Manandhar K., Holen A. et al.
Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience
Russo A., Tessitore A., Conte F. et al.
Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial
Gaul C., Diener H-C., Danesch U., on behalf of the Migravent® Study Group
Field testing primary stabbing headache criteria according to the 3rd beta edition of International Classification of Headache Disorders: a clinic-based study
Lee M., Chu M.K., Lee J. et al.
(Publication years 2015-2016. Data collected June 2016. Source: Altmetric)
Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Assistant to the Editor: Valerio De Angelis
"The Journal of Headache and Pain travels full steam ahead as it reaches its 17th year. Its inclusive policy has allowed well-founded new scientific groups to enter in the headache field and to fill the gap between the enormous quantity of patients and the number of scientists dedicated to headache research. The journal has achieved this year an Impact Factor of 3.497, ranking it second in the field of headache research. I want to particularly thank the Editorial Board who have contributed to this great achievement, and most of all the authors who trusted the journal for their publications or have cited the journal elsewhere. A special thanks goes to the affiliated Societies, European Headache Federation and Lifting The Burden." Paolo Martelletti, MD
The Journal of Headache and Pain is specifically dedicated to researchers involved in all aspects of headache and related pain, including theory, methodology, clinical practice and care. The journal's scope is broad, reflecting the wide application of scientific advances to every branch of headache and related pain management. Within a multidisciplinary perspective, the Journal covers headache and related pain syndromes in the following fields: genetics, neurology, internal medicine, clinical pharmacology, child neuropediatrics, anesthesiology, rheumatology, otology, dentistry, neurotraumatology, neurosurgery, psychiatry, pain management, and addiction.
The winner of the Greppi Award 2016 is:
MD, PhD, Senior Consultant
Department of Neurology
Karolinska University Hospital
With the manuscript:
Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets
The full list of authors is:
Anna Steinberg, Simona D Frederiksen, Frank W Blixt, Karin Warfvinge, Lars Edvinsson
The 2016 Greppi Award Lecture will be held in Glasgow, during the 5th European Headache and Migraine Trust International Congress, Sunday 18 September 2016.
The manuscript has been accepted for publication in The Journal of Headache and Pain
The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.
For more information:
Master in Headache Medicine - 14th Edition
Academic Year 2016-2017
Master of Headache Disorders - 1st Edition
Academic Years 2016-2018
The EFIC has created a task force on headache, aiming to face through the European Joint Campaign against Headache the problems connected to the shared research, the multidisciplinary treatment of borderline forms and the shared education.
The Joint Campaign against Headache is promoted by EFIC, EHF and LTB through the action of Task Force on Headache and seeks to increase the value of headache global impact, research and education. For further information on this initiative, please visit the homepage of the Joint Campaign against Headache.